← Back to Search

Blood Collection Device

TAP20-C for Diabetes

N/A
Waitlist Available
Research Sponsored by Seventh Sense Biosystems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group

Summary

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Non-Inferiority of Analyte Levels

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TAP20-CExperimental Treatment1 Intervention
TAP20-C
Group II: FingerstickActive Control1 Intervention
Fingerstick

Find a Location

Who is running the clinical trial?

Seventh Sense BiosystemsLead Sponsor
2 Previous Clinical Trials
2 Trials studying Diabetes
~11 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top